Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/SLA.0000000000001089 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A study of intersphincteric resection rate following robotic-assisted total mesorectal excision versus laparoscopic-assisted total mesorectal excision for patients with middle and low rectal cancer: study protocol for a multicenter randomized clinical trial.
Trials
October 2024
Department of Gastrocolorectal Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, China.
Introduction: Robotic-assisted complete mesorectal excision (RATME) is increasingly being used by colorectal surgeons. Most surgeons consider RATME a safe method, and believe it can facilitate total mesorectal excision (TME) in rectal cancer, and may potentially have advantages over intersphincteric resection (ISR) and anus preservation. Therefore, this trial was designed to investigate whether RATME has technical advantages and can increase the ISR rate compared with laparoscopic-assisted TME (LATME) in patients with middle and low rectal cancer.
View Article and Find Full Text PDFA Prospective European Trial Comparing Laparotomy, Laparoscopy, Robotic-Assisted, and Transanal Total Mesorectal Excision Procedures in High-Risk Patients with Rectal Cancer: The RESET Trial.
Ann Surg
September 2024
Department of Colorectal Surgery, CHU Estaing, Clermont-Ferrand, France.
Article Synopsis
- The study aimed to compare various total mesorectal excision (TME) techniques combined with sphincter-sparing procedures in high-risk rectal cancer patients.
- It involved a multicenter trial with over 1,000 patients, analyzing techniques like laparotomy, laparoscopy, robotic-assisted surgery, and transanal surgery to assess surgical outcomes.
- Results indicated that while all techniques had similar rates of successful resections, none met the anticipated success rate, and the outcomes were comparable among different surgical approaches, especially for minimally invasive methods.
Minimally Invasive Surgery for Hirschsprung Disease: Current Practices and Future Directions.
Cureus
August 2024
Internal Medicine, Ibrahim Malik Teaching Hospital, Khartoum, SDN.
Hirschsprung disease (HD) is a congenital disorder characterized by the absence of ganglion cells in the distal colon and rectum, leading to functional obstruction and severe constipation. Over the past decades, the surgical management of HD has significantly evolved, with minimally invasive surgery (MIS) techniques revolutionizing treatment approaches. This review explores recent innovations in MIS for HD, focusing on laparoscopic, transanal endorectal pull-through (TERPT), and robotic-assisted techniques.
View Article and Find Full Text PDFInitial case series experience with robotic-assisted transanal minimally invasive surgery performed with da Vinci single-port system for the excision of rectal cancer.
Surg Endosc
November 2024
Department of Surgery, University of Ulsan College of Medicine, Ulsan University Hospital, 15, Daehakbyeongwon-ro, Dong-gu, Ulsan, South Korea.
Background: Transanal minimally invasive surgery (TAMIS) is widely used for rectal lesion excision. Robot-assisted TA TAMIS (R-TAMIS) may improve surgical ergonomics. The introduction of the da Vinci Single-Port (SP) robot, designed for endoluminal surgery, has brought new possibilities.
View Article and Find Full Text PDFRobot-assisted transanal minimally invasive surgery for the treatment of rectal adenocarcinoma.
J Surg Oncol
September 2024
Department of Health Sciences, Hospital Israelita Albert Einstein, São Paulo, Brazil.
This is a video vignette of a 57-year-old asymptomatic female patient. The patient underwent a screening colonoscopy which revealed a 10 mm scar in the rectum. Biopsy resulted in a well-differentiated tubular adenocarcinoma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!